Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET

被引:0
|
作者
Park, Yong-Jin [1 ]
Moon, So Young [2 ]
Yoon, Joon-Kee [1 ]
Lee, Su-Jin [1 ]
An, Young-Sil [1 ,3 ]
机构
[1] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[2] Ajou Univ, Dept Neurol, Sch Med, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Nucl Med & Mol Imaging, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea
来源
EJNMMI RESEARCH | 2025年 / 15卷 / 01期
关键词
Amyloid; Positron emission tomography; Flutemetamol; Cutoff; CortexID suite; VALIDATION;
D O I
10.1186/s13550-024-01193-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background This study aimed to establish the optimal cutoff values for visual amyloid positivity using standardized uptake value ratios (SUVRs) in [F-18]flutemetamol (FMM) positron emission tomography (PET) imaging. Given the variability in amyloid assessment, our goal was to determine cutoff values that enhance diagnostic accuracy and assist clinicians in reliably identifying amyloid positivity. Results The identified cutoff values for visual amyloid positivity were > 1.6 for the cerebellar gray matter, > 1.38 for the whole cerebellum, and > 0.63 for the pons, yielding high sensitivity (95.5%, 94.5%, and 95.8%, respectively) and specificity (91.2%, 94.3%, and 95.2%, respectively). Conclusions The SUVR cutoff values demonstrated excellent diagnostic performance, supporting their clinical use in assessing visual amyloid positivity in [F-18]FMM PET imaging.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] FLUTEMETAMOL (18F): A β-AMYLOID POSITRON EMISSION TOMOGRAPHY TRACER FOR ALZHEIMER'S AND DEMENTIA DIAGNOSIS
    de Lartigue, J.
    DRUGS OF TODAY, 2014, 50 (03) : 219 - 229
  • [22] Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
    Mark R. Battle
    Lovena Chedumbarum Pillay
    Val J. Lowe
    David Knopman
    Bradley Kemp
    Christopher C. Rowe
    Vincent Doré
    Victor L. Villemagne
    Christopher J. Buckley
    EJNMMI Research, 8
  • [23] Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
    Battle, Mark R.
    Pillay, Lovena Chedumbarum
    Lowe, Val J.
    Knopman, David
    Kemp, Bradley
    Rowe, Christopher C.
    Dore, Vincent
    Villemagne, Victor L.
    Buckley, Christopher J.
    EJNMMI RESEARCH, 2018, 8
  • [24] Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis
    Leuzy, Antoine
    Savitcheva, Irina
    Chiotis, Konstantinos
    Lilja, Johan
    Andersen, Pia
    Bogdanovic, Nenad
    Jelic, Vesna
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (06) : 1276 - 1286
  • [25] Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis
    Heurling, Kerstin
    Leuzy, Antoine
    Zimmer, Eduardo R.
    Lubberink, Mark
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 362 - 373
  • [26] Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
    Collij, Lyduine E.
    Konijnenberg, Elles
    Reimand, Juhan
    ten Kate, Mara
    den Braber, Anouk
    Alves, Isadora Lopes
    Zwan, Marissa
    Yaqub, Maqsood
    van Assema, Danielle M. E.
    Wink, Alle Meije
    Lammertsma, Adriaan A.
    Scheltens, Philip
    Visser, Pieter Jelle
    Barkhof, Frederik
    van Berckel, Bart N. M.
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (04) : 541 - 547
  • [27] The Early Perfusion Image Is Useful to Support the Visual Interpretation of Brain Amyloid-PET With 18F-Flutemetamol in Borderline Cases
    Mathies, Franziska L.
    Heeman, Fiona
    Visser, Pieter Jelle
    den Braber, Anouk
    Yaqub, Maqsood
    Klutmann, Susanne
    Schoell, Michael
    van de Giessen, Elsmarieke
    Collij, Lyduine E.
    Buchert, Ralph
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 838 - 846
  • [28] Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
    Milos D. Ikonomovic
    Enrico R. Fantoni
    Gill Farrar
    Stephen Salloway
    Alzheimer's Research & Therapy, 10
  • [29] Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis
    Kerstin Heurling
    Antoine Leuzy
    Eduardo R. Zimmer
    Mark Lubberink
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 362 - 373
  • [30] In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol
    Snellman, Anniina
    Rokka, Johanna
    Lopez-Picon, Francisco R.
    Eskola, Olli
    Salmona, Mario
    Forloni, Gianluigi
    Scheinin, Mika
    Solin, Olof
    Rinne, Juha O.
    Haaparanta-Solin, Merja
    EJNMMI RESEARCH, 2014, 4 : 1 - 11